Cite
Scheffer IE, Hulihan J, Messenheimer J, et al. Safety and Tolerability of Transdermal Cannabidiol Gel in Children With Developmental and Epileptic Encephalopathies: A Nonrandomized Controlled Trial. JAMA Netw Open. 2021;4(9):e2123930doi: 10.1001/jamanetworkopen.2021.23930.
Scheffer, I. E., Hulihan, J., Messenheimer, J., Ali, S., Keenan, N., Griesser, J., Gutterman, D. L., Sebree, T., & Sadleir, L. G. (2021). Safety and Tolerability of Transdermal Cannabidiol Gel in Children With Developmental and Epileptic Encephalopathies: A Nonrandomized Controlled Trial. JAMA network open, 4(9), e2123930. https://doi.org/10.1001/jamanetworkopen.2021.23930
Scheffer, Ingrid E, et al. "Safety and Tolerability of Transdermal Cannabidiol Gel in Children With Developmental and Epileptic Encephalopathies: A Nonrandomized Controlled Trial." JAMA network open vol. 4,9 (2021): e2123930. doi: https://doi.org/10.1001/jamanetworkopen.2021.23930
Scheffer IE, Hulihan J, Messenheimer J, Ali S, Keenan N, Griesser J, Gutterman DL, Sebree T, Sadleir LG. Safety and Tolerability of Transdermal Cannabidiol Gel in Children With Developmental and Epileptic Encephalopathies: A Nonrandomized Controlled Trial. JAMA Netw Open. 2021 Sep 01;4(9):e2123930. doi: 10.1001/jamanetworkopen.2021.23930. PMID: 34477852; PMCID: PMC8417764.
Copy
Download .nbib